Skip to main content
. 2017 Feb 27;8(35):59757–59765. doi: 10.18632/oncotarget.15760

Figure 2. RFS according to immunologic groupings of a low NLR, high LMR, and PLR.

Figure 2

IG3 patients showed a significantly better RFS rate regardless of other prognostic factors.